Cambridge's Surface Oncology Promotes CBO to Top Job

  • Post author:
  • Post category:BioPharma

Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors.
Source: BioSpace